RxDoctor Payments DataLook up a doctor →

Maria Martin Lopes

Cresskill, NJNPI 1093969784

Payments from drug & device makers

$775,877in general payments, 2019–2025

Across 659 payments — averaging $1177.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$161K
  • Pfizer$101K
  • Sanofi$70K
  • EMD Serono, Inc.$51K
  • Medtronic$49K
  • Boehringer Ingelheim$33K
  • plus $309K from 51 others

What the payments were for

  • Consulting fees$569,21373%
  • Speaking & faculty fees$117,92115%
  • Travel & lodging$73,83210%
  • Food & beverage$14,9122%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bayer200$161,375
Pfizer58$101,310
Sanofi35$70,124
EMD Serono, Inc.28$51,043
Medtronic26$49,272
Boehringer Ingelheim16$33,353
Regeneron Healthcare Solutions, Inc.21$22,860
Genentech, Inc.24$21,412
Genentech USA, Inc.21$19,810
Otsuka America Pharmaceutical, Inc.13$16,296
UCB, Inc.26$14,441
LEO Pharma Inc.4$14,095
Novo Nordisk9$11,823
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)15$11,269
Amgen(2 entities)6$11,124
Pacira Pharmaceuticals Incorporated9$10,010
Alkermes, Inc.6$9,342
Regeneron10$9,281
Novo Nordisk AS6$8,980
AbbVie(2 entities)10$8,698
Novartis9$8,519
CSL Behring5$7,825
Jazz Pharmaceuticals Inc.9$7,629
Seagen Inc.10$7,400
Supernus Pharmaceuticals, Inc.5$6,960
Pharmacyclics LLC, An Abbvie Company12$5,452
Roche Diagnostics Corporation8$5,250
H. Lundbeck A S2$5,020
Myovant Sciences Inc.2$4,930
Bristol Myers Squibb1$4,920
Incyte Corporation2$4,748
MDD US Operations, LLC2$4,500
Omeros Corporation9$4,315
Insmed, Inc.3$4,102
Mylan Specialty L.p.7$4,091
Lundbeck LLC2$3,750
Biogen1$3,200
Sage Therapeutics, LLC3$2,800
Ferring Pharmaceuticals Inc.1$2,750
Sobi, Inc1$2,212
Gilead1$2,140
Hikma Pharmaceuticals USA1$2,063
Takeda Pharmaceuticals U.S.A., Inc.1$2,000
Oyster Point Pharma, Inc.1$1,800
Bioventus LLC1$1,750
Otsuka Pharmaceutical Development & Commercialization, Inc.1$1,600
Eisai Inc.1$1,290
Evoke Pharma, Inc.1$1,200
Daiichi Sankyo Inc.1$1,000
Genmab U.S., Inc.2$1,000
Pulse Biosciences, Inc.1$750
Y-mabs Therapeutics, Inc.1$750
Sandoz1$657
Teva Pharmaceuticals USA, Inc.2$475
Amneal Pharmaceuticals LLC1$458
Johnson & Johnson2$371
Mylan Pharmaceuticals Inc.3$285

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →